Status:
RECRUITING
Immersive Virtual Reality Meditation in Voice Therapy
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
Voice Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to explore the feasibility of incorporating regular guided meditations via immersive virtual reality (IVR) at the start of voice therapy sessions to facilitate better learning and rete...
Eligibility Criteria
Inclusion
- Patients with voice disorders, difficulties or laryngeal hypersensitivity, and who also have anxiety
- Must have availability to participate for entire course of 5 consistent weeks
Exclusion
- Anyone not meeting inclusion criteria
- Presence of any additional medical condition significantly affecting:
- Respiratory function (e.g., advanced lung disease)
- Laryngeal function (e.g., status-post deep brain stimulation)
- Lingual function
- Velopharyngeal function (e.g., laryngectomy)
Key Trial Info
Start Date :
March 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 6 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07176013
Start Date
March 3 2025
End Date
December 6 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Downtown Union Square
New York, New York, United States, 10003